baber/WOPTO huggingface dataset:
Patent FI-945075-A0 (FI)
Inventor: VAZVAN BEHRUZ
IPC: H04W4/24
Filed: 1994-10-28
Abstract: This invention is a real time mobile payment system and a method that relates to the payments and bills of the mobile users and providing the mobile users with the information about their accounts, account balance, the statement of account, or the movement on the account and other required messages by using their mobile terminals (1, 6) under any wireless telecommunication system. According to one embodiment of the invention short message service facilities of at least one mobile wireless communication network (4) or a digital cordless communication system (5) are utilized through which user mobile terminals (1, 6) can send and receive to or from remote computing stations (2) payment messages and/or at least messages about the account balance, the statement of account, or the movement on the account of said mobile terminal's subscriber or user, and communicating banking, payment, and/or commerce related and other required messages. The system in one of its embodiments characterized in that means are provided for encrypting/decrypting and completely securing messages communicated between a mobile terminal (1, 6) and/or a identity module (10, 21, 39, 42) such as SIM (Subscriber Identity Module) or equivalent and a computing station using a security algorithm. <IMAGE>   <IMAGE>
Patent FI-950465-A0 (FI)
Inventor: ROLF DAVID
IPC: A61F13/02
Filed: 1995-02-02
Abstract: A non-occlusive medication patch (32) to be applied to the skin includes a porous self-supporting backing layer (10) to give the patch the required integrity and strength by acting as a supporting framework for other components, and a flexible hydrophilic pressure-sensitive adhesive reservoir (20) comprising a natural or synthetic polymer for the sustained release of medication to be absorbed topically through the skin into the body of a patient. The reservoir has two portions: first, an external coating layer (24) with an exposed lower skin-contacting surface (24b) that forms a pressure-sensitive bond with the skin, and second, an upper internal portion (24a) which infiltrates the porous backing (10) and becomes solidified therein after being applied so that the reservoir and the backing are unified, enabling the backing itself to act as a storage location for the medication-containing reservoir (20). The medication within the reservoir migrates over time from within the backing (10) through the lower coating layer (24b) and passes through the skin to provide sustained release of the medication into the body of a patient. <IMAGE>
Patent FI-955095-A0 (FI)
Inventor: LAPLANTE BENOIT
IPC: B65H18/00
Filed: 1995-10-25
Abstract: The method is for producing a first primary roll having a predetermined lateral surface defined by a diameter Df. The primary roll is made of material wound around a spindle. The material is used to produce smaller secondary rolls of material. The method comprises steps of (a) calculating a portion Sf of the lateral surface, which is covered by the spindle; (b) calculating a portion Si of the lateral surface, Which represents material needed to produce the smaller secondary rolls of material; (c) calculating a compression factor K1 which is derived from a compression rate K of a previous second primary roll used to produce previous secondary rolls with respect to the previous secondary rolls; (d) calculating Df where:   <IMAGE>   (e) winding up material around the spindle to produce the first primary roll until a diameter of the first primary roll reaches said diameter Df; whereby loss of material is reduced by taking into account compression factor K1 which varies with respect to time. An apparatus to perform the present method is also provided.
Patent FI-961758-A0 (FI)
Inventor: FUJIWARA SHIGEKI
IPC: A61P9/00
Filed: 1996-04-24
Abstract: Disclosed are quinazoline derivatives represented by formula (I):   <CHEM> wherein R<1> represents hydrogen, lower alkyl, alkenyl, or aralkyl; R<2>, R<3>, R<4>, and R<5> represent hydrogen, lower alkyl, lower alkoxy, lower alkanoyl, or the like; R<6>, R<7>, R<8>, and R<9> represent hydrogen, lower alkyl, lower alkoxy, aralkyloxy, or the like, or any adjoining two of them are combined to form methylenedioxy or the like; R<10> represents hydrogen, lower alkyl, or the like; R<11> and R<12> represent hydrogen, lower alkyl, cycloalkyl, phenyl, or aralkyl, or R<11> and R<12> are combined together with N to form a heterocyclic group; and n represents 0, 1 or 2,  and pharmaceutically acceptable salts thereof. These compounds have adenosine uptake inhibitory activity and are useful for the protection of myocardium and for the prevention or treatment of inflammation such as leg and foot edema.
Patent FI-972337-A0 (FI)
Inventor: HOLM NIELS ERIK
IPC: B04B5/00
Filed: 1997-06-02
Abstract: A method and a device for separating a component, such as fibrin I from blood, by centrifugation. The method involves feeding of blood admixed an anticlotter to a first annular chamber in a device, where the annular chamber is defined by a cylindrical outer wall and a cylindrical inner wall, both walls extending coaxially about a common axis, as well as by a top wall and a bottom wall, where the top wall or the bottom wall is formed by a piston body displaceable within the first chamber. The method involves furthermore a centrifugation of the device about the said common axis followed by a resulting liquid fraction being transferred while influenced by the piston body to a second chamber defined by an outer cylindrical wall, which extends coaxially with said common axis. As a result the liquid fraction present in the second chamber is caused to be further separated by a continued centrifugation and addition of suitable compositions promoting the separation and returning of the non-utilizable portion to the first chamber. In addition, the portion of the liquid fraction remaining in the second chamber is transferred to a liquid-receiving container through a filter optionally after addition of a solvent. The portion of the liquid fraction remaining in the second chamber prior to the transfer to the liquid-receiving container is transferred to a third chamber coaxially accommodated with the other chambers, and the liquid now present in said third chamber is caused to pass through an annular filter during the centrifugation so as to enter an annular outer compartment which is adapted to be connected to the liquid-receiving member.
Patent AP-8600049-A0 (AP)
Title: Clamps.
Inventor: BENISCHKE HEINZ DIETER ANTON
IPC: F16G11/06
Filed: 1986-11-14
Abstract: A clamp comprises a pair of identical plates (44)forming a connector plate (16)and a pair of clamping arms (12, 14)pivitally connected to the connector plate (16)at spaced locations (50, 52). A nut (18)and a bolt (20)located at the ends (26)of the arms (12, 14)rotate from the connector plate (16)holds the clamping arms (12, 14)together. The nut (18)is carried by one arm (14)to pivot about an axis (54)at right angles to its bore (56). The bolt (20)passes through a slot (60)in the other arm (12)and is capable of swinging free from said other arms.
Patent IL-57627-A0 (IL)
Title: Imidazo(1,2-a)imidazole derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07D235/00
Filed: 1979-06-22
Abstract: Compounds of the formula   <IMAGE>   wherein R1, R2 and R3, which may be identical to or different from each other, are each hydrogen, fluorine, chlorine, bromine, methyl, methoxy or trifluoromethyl, provided that one of them is other than hydrogen; and R4 and R5, which may be identical to or different from each other, are each hydrogen or methyl; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as bradycardiacs.
Patent IL-70884-A0 (IL)
Title: Substituted n-phenyl-n'-benzoylureas,their preparation and their use as pesticides
IPC: C07D207/34
Filed: 1984-02-07
Abstract: Novel substituted N-pyrrolylphenyl-N'-benzoylurea compounds of the formula   <IMAGE>   in which X and Y independently of one another are each hydrogen or halogen, R is hydrogen or halogen, and Z is hydrogen, halogen or methyl. The compounds have valuable properties for controlling pests, such as phytoparasitic and zooparasitic insects and members of the order Acarina, including in particular ectoparasites.
Patent IL-74628-A0 (IL)
Title: Insert for a water purifier
IPC: C02F9/00
Filed: 1985-03-17
Abstract: Described is an insert for a water purifier comprising substantially cylindrical side walls (9) with a filter top (16) and a filter bottom (10) at the end thereof, and with an annular sealing means (12, 22) secured to the upper end of the side walls (9). In order to increase the volume and in particular the length of the flow path of the liquid to be purified, through the purification agent, it is provided in accordance with the invention that the insert comprises a distributor and a cup portion (11) connected thereto, which respectively have at least a guide tube (13, 17) extending into the interior of the insert and an annular flange (12) for securing to the other annular flange (22), that the guide tubes (13, 17) are of different diameters and in the assembled condition are in concentric relationship with each other, that the upper annular flange (22) is secured to the filter top (16) of the distributor, said filter top having an end wall (21) and filter slots (23) in a cylindrical wall (20), an that filter means are provided at the inner guide tube (13).
Patent IL-83823-A0 (IL)
Title: Compositions for inducing binding between parts of living mineralized tissue
IPC: C12P21/00
Filed: 1987-09-08
Abstract: A composition for use in inducing binding between parts of living mineralized tissue by regeneration of mineralized tissue on at least one of the parts, characterized in that it contains as an active constituent a precursor to dental enamel, so called enamel matrix; process for inducing binding between parts of mineralized tissue using such composition.
Patent IL-84811-A0 (IL)
Title: Appliance for injection of liquid formulations
IPC: A61M5/178
Filed: 1987-12-14
Abstract: The portable appliance is of use for the subcutaneous or intradermal injection of a liquid formulation of an active principle and it comprises in combination: a supply vessel for the formulation; an injection needle adapted to communicate with the vessel; pump means for emptying the vessel through the injection needle; securing means for securing the appliance to an appropriate part of the patient's body; and needle-driving means for shooting the injection needle into the patient's skin.
Patent IL-85640-A0 (IL)
Title: 1-(1-aryl-2-hydroxyethyl)-imidazoles and salts thereof,processes for the preparation thereof and pharmaceutical compositions containing them
IPC: C07D405/06
Filed: 1988-03-06
Abstract: 1-(1-Aryl-2-hydroxyethyl)-imidazoles and salts thereof, processes for the preparation thereof, medicaments containing these compounds, and the use thereof. The invention relates to 1-(1-aryl-2-hydroxyethyl)-imidazoles of the formula I   <IMAGE> I  in which R1, R2, R3, Q, W, X and Y have the meanings specified, and also to medicaments based on these compounds, in particular those having an antimycotic and an antidepressive action.
Patent IL-88020-A0 (IL)
Title: Oral formulation of buspirone and salts thereof
IPC: A61K31/505
Filed: 1988-10-12
Abstract: Oral controlled/extended release formulations of buspirone and salts thereof for increase of bioavailability and drug tolerability.
Patent IL-93173-A0 (IL)
Title: Production of glucagon
IPC: C07K14/605
Filed: 1990-01-25
Abstract: A novel method for producing glucagon is provided. The method comprises the steps of, preparing a fusion protein shown by the following formula:  X-Glu-Glucagon      (I) wherein X is a leader sequence of 70-170 amino acids, Glu is a glutamic acid residue, and Glucagon represents the amino acid sequence of glucagon, and treating the fusion protein with an enzyme that specifically hydrolyzes the peptide bonds at the carboxyl termini of the glutamic acid residues, resulting in cleavage of the fusion protein.
Patent IL-94277-A0 (IL)
Title: Production of potassium magnesium phosphate
IPC: C05B7/00
Filed: 1990-05-03
Abstract: A process for the preparation of potassium magnesium phosphate hexahydrate by reaction of calcium dihydrogen phosphate with potassium sulphate and a basic magnesium compound is described.
Patent IL-99580-A0 (IL)
Title: Antagonists of human gamma interferon
IPC: A61K38/00
Filed: 1991-09-26
Abstract: PCT No. PCT/US91/06771 Sec. 371 Date Mar. 19, 1993 Sec. 102(e) Date Mar. 19, 1993 PCT Filed Sep. 25, 1991 PCT Pub. No. WO92/06115 PCT Pub. Date Apr. 16, 1992.Novel synthetic polypeptides having amino acid sequences corresponding to the sequence of one or more specific regions of human gamma interferon are provided by this invention. These polypeptides specifically inhibit the binding of human gamma interferon to cellular receptors and the biological activity of such interferon. Antibody antagonists of the binding of human gamma interferon to cellular receptors based Upon the use of the polypeptides as antigens are also provided. Some of these antagonists bind to specific regions of gamma interferon which are believed to be involved in interactions between the intefferon and its receptors. Other antibody antagonists are anti-idiotypic antibodies which appear to compete directly with gamma interferon for binding to the cellular receptors. Also provided are methods for the use of the polypeptides and antibodies as inhibitors of the binding of gamma interferon to its cellular receptors.
Patent IL-99682-A0 (IL)
Title: Preparation of crystal-water-free crystalline lactulose
IPC: C07H3/04
Filed: 1991-10-09
Abstract: The present invention is concerned with a method for the preparation of crystal-water-free crystalline lactulose by subjecting an aqeous solution or suspension of lactulose to simultaneous reduction of the water content by evaporation and continuous stirring, optionally in the presence of seed crystals, until a free-flowing solid powder is obtained.
Patent FI-20000735-A0 (FI)
Inventor: CASAIS EDUARDO
IPC: H04M1/72445
Filed: 2000-03-30
Abstract: A method of browsing interactive data services with a wireless mobile device using a multi-modal technique for selecting components of an image. The method of browsing is particularly useful with mobile devices operation in accordance with Wireless Application Protocol (WAP) but is not limited thereto. A first mode of selection includes overlaying an image over a grid of cells on the display of the mobile device such as a mobile phone (FIG. 2). The cells are matched to a corresponding key on the keypad of the mobile phone. The user selects the cell containing the portion of the image of interest for further browsing by pressing the appropriate key. The cell contains a pointer to, e.g. a universal resource locator (URL) on the Internet, related information for retrieval and display on the phone. A second mode of selection includes using vocal identifiers matched to specific cells on a voice recognition capable phone or network. When the user speaks a recognized identifier, it is matched to the appropriated cell which is then selected to display the desired information.
Patent IL-102791-A0 (IL)
Title: Cyclic urethanes and pharmaceutical compositions containing them
IPC: A61K31/422
Filed: 1992-08-12
Abstract: Cyclic urethane compounds which are useful as antiarrhythmic and antifibrillatory agents, and the pharmaceutically-acceptable salts and esters thereof, characterized in that they have the general structure: <CHEM>       a) Y is an unsaturated, 5- membered heterocycle; b) R1, R2 and R3 are independently selected from hydrogen, Cl, F, Br, OH and CH3;   c) R4 is C1-C8 alkyl; d) A is substituted or unsubstituted, saturated or unsaturated, straight-chain or branched C1-C8 heteroalkyl, and A has at least one nitrogen atom which is adjacent to R4.
Patent IL-103614-A0 (IL)
Title: Anilide derivatives and their use for combating botrytis
IPC: C07D277/56
Filed: 1992-11-02
Abstract: Use of nicotinanilide derivatives of the general formula <IMAGE>  in which the substituents have the following meanings:   R<1> represents halogen, methyl, trifluoromethyl, methoxy, methylthio, methylsulphinyl, methylsulphonyl and R<2> represents alkyl which is optionally substituted by halogen, alkenyl which is optionally substituted by halogen, alkynyl, alkoxy which is optionally substituted by halogen, alkenyloxy which is optionally substituted by halogen, or alkynyloxy, cycloalkyl, cycloalkenyl, cycloalkyloxy or cycloalkenyloxy  for combating botrytis, and nicotin anilides of the formula I.
Patent IL-108892-A0 (IL)
Title: Aza cyclohexapeptide compounds and antimicrobial compositions containing them
IPC: C07K7/64
Filed: 1994-03-08
Abstract: Ceretain aza cyclohexapeptide compounds have been found to have superior antibiotic properties. Novel processes for their preparation are also described.
Patent IL-113010-A0 (IL)
Title: Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
IPC: A61K47/42
Filed: 1995-03-16
Abstract: PCT No. PCT/SE95/00348 Sec. 371 Date Sep. 17, 1996 Sec. 102(e) Date Sep. 17, 1996 PCT Filed Mar. 31, 1995 PCT Pub. No. WO95/26750 PCT Pub. Date Oct. 12, 1995The present invention relates to a pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration comprising coagulation factor VIII or factor IX and use thereof for manufacture of a medicament for treating haemophilia A or B. The formulation comprises coagulation factor VIII or factor IX with an activity of at least 200 IU/ml and an additive increasing the bio-availability of factor VIII or factor IX. Tests with factor VIII gives a therapeutic level of active factor VIII in the blood stream for a surprisingly long period of time after subcutaneous, intramuscular or intradermal administration. The factor VIII is suitably a highly purified recombinant factor VII, and preferably a deletion derivative thereof, which can be used for the manufacture of a medicament for subcutaneous administration.
Patent IL-115455-A0 (IL)
Title: Die assembly
Inventor: HECK ERNST
IPC: B29C48/315
Filed: 1995-09-28
Abstract: An extrusion die (1) has a fixed solid body (2) with an entry part (2) for the plastified extrusion material, partic. foodstuffs, and a housing (4) enclosing a rotating barrel (5) within which is an exit channel (6). Also in the housing is a distribution chamber (7) of revolution symmetry connected upstream with the entry part (3) and downstream with the exit channel (6). An external surface (8,9) of the barrel (5) co-operator via axial and radial bearings (10,11) with a corresponding surface (12,13) of the housing. Rotating annular sealing rings (15) provide a sealed joint between the housing and rotating barrel are made of stainless steel powder reinforced PTFE. The plastified material entry (3) extends transversally in the die body (2) and exits laterally in the distribution anti chamber (14) while the filling entry (26) extends axially in the body; and through the anti-chamber and distribution chamber (7) in the form of a coaxial tube (28) joined to the body.
Patent IL-126138-A0 (IL)
Title: New tetralone or benzopyranone derivatives and a method for producing them
IPC: C07D407/06
Filed: 1998-01-28
Abstract: The present invention provides new tetralone or benzopyranone derivatives and a method for producing the derivatives useful for a therapeutic agent for preventing and/or treating hormone dependent diseases. The present invention is a new tetralone or benzopyranone derivative represented by a particular general formula (I). <CHEM> wherein R1 and R2 represent hydrogen, a hydroxy group, an alkyloxy group or an aralkyloxy group, respectively, R3- R7 represent hydrogen, a hydroxy group or a straight or branched alkyl, alkyloxy or aralkyloxy group having 1-6 carbon atoms, a halogen, an amino group or an alkylene dioxy group joined at R3 and R4, R4 and R5, R5 and R6, or R6 and R7, respectively, and A represents a methylene or oxygen. In the production, a particular tetralone or benzopyranone compound and a particular benzaldehyde compound are reacted.
Patent IL-133212-A0 (IL)
Title: (Imidazol-5-yl) methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
IPC: C07D405/14
Filed: 1998-05-25
Abstract: This invention comprises the use of compounds of formula (I) wherein the dotted line represents an optional bond; X is oxygen or sulfur; R<SUP>1 </SUP>is hydrogen, C<SUB>1-12</SUB>alkyl, Ar<SUP>1</SUP>, Ar<SUP>2</SUP>C<SUB>1-6</SUB>alkyl, quinolinylC<SUB>1-6</SUB>alkyl, pyridylC<SUB>1-6</SUB>alkyl, hydroxyC<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkyloxyC<SUB>1-6</SUB>alkyl, mono- or di(C<SUB>1-6</SUB>alkyl)aminoC<SUB>1-6</SUB>alkyl, aminoC<SUB>1-6</SUB>alkyl, or a radical of formula -Alk<SUP>1</SUP>-C(-O)-R<SUP>9</SUP>, -Alk<SUP>1</SUP>-S(O)-R<SUP>9 </SUP>or -Alk<SUP>1</SUP>-S(O)<SUB>2</SUB>-R<SUP>9</SUP>; R<SUP>2</SUP>, R<SUP>3 </SUP>and R<SUP>16 </SUP>each independently are hydrogen, hydroxy, halo, cyano, C<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkyloxy, hydroxyC<SUB>1-6</SUB>alkyloxy, C<SUB>1-6</SUB>alkyloxyC<SUB>1-6</SUB>alkyloxy, aminoC<SUB>1-6</SUB>alkyloxy, mono- or di(C<SUB>1-6</SUB>alkyl)aminoC<SUB>1-6</SUB>alkyloxy, Ar<SUP>1</SUP>, Ar<SUP>2</SUP>C<SUB>1-6</SUB>alkyl, Ar<SUP>2</SUP>oxy, Ar<SUP>2</SUP>C<SUB>1-6</SUB>alkyloxy, hydroxycarbonyl, C<SUB>1-6</SUB>alkyloxycarbonyl, trihalomethyl, trihalomethoxy, C<SUB>2-6</SUB>alkenyl; R<SUP>4 </SUP>and R<SUP>5 </SUP>each independently are hydrogen, halo, Ar<SUB>1</SUB>, C<SUB>1-6</SUB>alkyl, hydroxyC<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkyloxyC<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkyloxy, C<SUB>1-6</SUB>alkylthio, amino, hydroxycarbonyl, C<SUB>1-6</SUB>alkyloxycarbonyl, C<SUB>1-6</SUB>alkylS(O)C<SUB>1-6</SUB>alkyl or C<SUB>1-6</SUB>alkylS(O)<SUB>2</SUB>C<SUB>1-6</SUB>alkyl; R<SUP>6 </SUP>and R<SUP>7 </SUP>each independently are hydrogen, halo, cyano, C<SUB>1-6</SUB>alkyl, 4,4-dimethyl-oxazolyl, C<SUB>1-6</SUB>alkyloxy or Ar<SUP>2</SUP>oxy; R<SUP>8 </SUP>is hydrogen, C<SUB>1-6</SUB>alkyl, cyano, hydroxycarbonyl, C<SUB>1-6</SUB>alkyloxycarbonyl, C<SUB>1-6</SUB>alkylcarbonylC<SUB>1-6</SUB>alkyl, cyanoC<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkyloxycarbonylC<SUB>1-6</SUB>alkyl, carboxyC<SUB>1-6</SUB>alkyl, hydroxyC<SUB>1-6</SUB>alkyl, aminoC<SUB>1-6</SUB>alkyl, mono- or di(C<SUB>1-6</SUB>alkyl)aminoC<SUB>1-6</SUB>alkyl, imidazolyl, haloC<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkyloxyC<SUB>1-6</SUB>alkyl, aminocarbonylC<SUB>1-6</SUB>alkyl, or a radical of formula -O-R<SUP>10</SUP>, -S-R<SUP>10</SUP>, -N-R<SUP>11</SUP>R<SUP>12</SUP>; R<SUP>17 </SUP>is hydrogen, halo, cyano, C<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkyloxycarbonyl, Ar<SUB>1</SUB>; R<SUP>18 </SUP>is hydrogen, C<SUB>1-6</SUB>alkyl, C<SUB>1-6</SUB>alkyloxy or halo; R<SUP>19 </SUP>is hydrogen or C<SUB>1-6</SUB>alkyl; for the manufacture of a medicament to inhibit smooth muscle cell proliferation.